These studies demonstrate that the impact of JAK2-mutant CHIP on the risk of VTE may be greater than common heterozygous inherited thrombophilias, although the prevalence of JAK2-mutant CHIP is lower than these germ line risk alleles. The gene discussed is JAK2; the disease is Rare hereditary thrombophilia.